Super Micro Computer Stock: SMCI Slides as $7 Billion AI Financing Fuels Dilution Fears

Super Micro Computer Stock: SMCI Slides as $7 Billion AI Financing Fuels Dilution Fears

New York, June 14, 2026, 12:03 EDT

Super Micro Computer’s stock enters the new week under pressure after the AI-server maker priced a large equity and equity-linked financing package, leaving investors to weigh a huge order pipeline against near-term dilution. SMCI was last quoted at $30.46, down 4.8% from the previous close, with intraday volume of about 84.9 million shares and a market value near $21.1 billion. The move contrasted with a firmer tape for large-cap tech proxies such as QQQ, which was up 0.59% at its latest quote, suggesting the weakness was largely company-specific.

The latest filing shows Supermicro priced 45.45 million common shares at $27.50 each and 75 million depositary shares at $50 each, tied to newly issued 7.0% Series A mandatory convertible preferred stock. Mandatory convertible preferred stock is a security that pays a preferred dividend but later converts into common shares, which can dilute existing shareholders. Supermicro also set up a $1.25 billion at-the-market, or ATM, program, which allows a company to sell new shares into the open market over time rather than all at once.

The stock-price problem is simple: the financing helps Supermicro buy components for AI servers, but it also increases the future share count. Dilution means existing investors own a smaller percentage of the company after new shares or convertible securities are issued. Supermicro said the combined gross proceeds, including potential ATM sales and underwriters’ options, represent a total potential equity raise of $7.0 billion, and the company plans to use part of the proceeds to support roughly $39 billion of recent advanced AI-server orders from more than 20 customers.

The bull case is that the financing is a sign of demand, not distress: Supermicro says it needs capital to buy components for a much larger order opportunity. The company’s last reported quarter also showed net sales of $10.2 billion, more than double the year-earlier period, while gross margin — the percentage of revenue left after production costs — improved to 9.9% from 6.3% in the previous quarter. For fiscal 2026, management guided to revenue of $38.9 billion to $40.4 billion.

The bear case is that the order figure may not be as solid as the headline suggests. In the offering materials, Supermicro warned that the $39 billion of AI orders are not firm commitments and remain subject to cancellation, delays and other conditions. Investors are also focused on cash intensity: in the March quarter, Supermicro used $6.6 billion in operating cash flow and had $1.3 billion in cash against $8.8 billion of bank debt and convertible notes as of March 31.

Analyst sentiment remains cautious rather than broadly bullish. Investor’s Business Daily reported that Wedbush analyst Matt Bryson kept a neutral rating and a $34 price target after the financing news, while noting strong order momentum alongside continuing concerns tied to an earlier criminal case involving alleged illicit technology exports to China. Reuters reported in March that U.S. prosecutors charged three people linked to Super Micro, including a co-founder, while the company was not named as a defendant and said it had cooperated with investigators.

The next major catalyst is the expected June 15 closing of the depositary-share offering, followed by evidence in the fiscal fourth-quarter update that the AI orders are converting into revenue, margin and cash flow. Supermicro’s fourth quarter runs through June 30, and investors will be watching whether the company can meet its $11.0 billion to $12.5 billion quarterly revenue outlook without sacrificing margins or needing still more capital.

At about 14.6 times earnings — price-to-earnings ratio, or the share price divided by earnings per share — SMCI does not look expensive on a simple valuation screen. But based on the verified facts today, the stock looks risky rather than plainly attractive: the AI demand story is real, but the financing structure, non-firm order language, heavy working-capital needs, and compliance overhang make execution the key issue for the share price.

Roman Perkowski

Roman Perkowski is a senior markets reporter at TS2.tech. His coverage ranges from stocks and technology to economic developments across global markets. He graduated from the Cracow University of Economics and worked in investment research and corporate finance before becoming a financial journalist. Follow Roman Perkowski on Google News.

US Stock Market Today Updates

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Kodiak Gas Services

NYSE:KGS • Energy infrastructure 88/100 • ★★★★☆
#2 STRONG BUY

Neurocrine Biosciences

NASDAQ:NBIX • Healthcare 87/100 • ★★★★☆
#3 STRONG BUY

Alphabet Class A

NASDAQ:GOOGL • Communication services 85/100 • ★★★★☆
#4 BUY ON WEAKNESS

Applied Materials

NASDAQ:AMAT • Semiconductor equipment 84/100 • ★★★★☆
#5 ACCUMULATE

JPMorgan Chase

NYSE:JPM • Financials 80/100 • ★★★★☆
View full portfolio
Editorial model selection. Not personalised advice.
MARKET CALENDAR

Key Events Today

The catalysts most likely to move markets.

#1

Consumer Confidence • 10:00 ET

A large surprise can reset expectations for household spending and near-term growth, with read-through to Treasuries, USD and cyclical stocks.

#2

New Home Sales • 10:00 ET

Housing remains highly rate-sensitive; the print can move homebuilders, mortgage-sensitive names and the long end of the Treasury curve.

#3

Intuit earnings • After close

Guidance can influence software multiples and sentiment around U.S. small-business activity.

View full calendar
Times and estimates may change. Verify before trading.
Emirates A380 July Network Reaches 48 Cities After June Cuts
Previous Story

Emirates A380 July Network Reaches 48 Cities After June Cuts

AtaiBeckley climbs after kicking off Phase 3 for BPL-003 in depression
Next Story

AtaiBeckley climbs after kicking off Phase 3 for BPL-003 in depression